Europe Multiple Sclerosis Treatment Market Growth, Overview with Detailed Analysis 2024-2030

Spread the love

The Europe Multiple Sclerosis (MS) Treatment Market was valued at USD 7.44 billion in 2023. The market is projected to grow at a compound annual growth rate (CAGR) of 6.9% from 2024 to 2030, reaching approximately USD 11.87 billion.
Europe Multiple Sclerosis Treatment Market Overview:

Multiple sclerosis (MS) is a disease that disrupts cognitive, emotional, motor, sensory, and visual functions due to the immune system attacking the brain and spinal cord.

The market dynamics for multiple sclerosis treatment in Europe encompass various growth drivers, opportunities, challenges, and constraints. The report provides a detailed analysis of these factors, including the strategies employed by market leaders to offer valuable insights to stakeholders. Recent developments, mergers, and acquisitions among key players are also examined to understand the evolving landscape of the MS treatment market in Europe.

Access comprehensive details about this research at this link:https://www.stellarmr.com/report/req_sample/Europe-Multiple-Sclerosis-Treatment-Market/1765

Europe Multiple Sclerosis Treatment Market Dynamics:

Drivers of Growth: The rapid advancement in research and development is creating significant opportunities for market expansion. Innovations in treatment technologies, such as drug formulations, are key drivers of market growth in Europe. Increased public awareness about MS and its treatment has also contributed to market expansion.

The rising prevalence of MS and heightened public awareness have led to more diagnoses and earlier treatment, further stimulating market growth. Additionally, the growing demand for healthcare services in Europe is a contributing factor.

Challenges: The expanding array of approved treatments for MS has made it challenging to select the most suitable therapy for individual patients. Evidence indicates that early treatment with highly effective therapies can reduce disability progression but may also pose risks of severe side effects, including infections, cardiac issues, liver damage, or increased susceptibility to autoimmune diseases.

Moreover, a significant lack of awareness about MS symptoms among the public (68%) and healthcare professionals (59%) hampers effective treatment and market growth. The heterogeneity of MS, both clinically and pathologically, complicates treatment, further exacerbated by adverse effects related to immune suppression.

Europe Multiple Sclerosis Treatment Market Segment Analysis:

By Treatment Type: Immunomodulators lead the market and are expected to maintain this position during the forecast period. These drugs modify immune system activity to enhance or suppress immune responses and are used in treating conditions such as cancer and autoimmune diseases.

Teriflunomide, an oral immunomodulatory agent, works by inhibiting dihydroorotate dehydrogenase, which is crucial in pyrimidine synthesis, and is used for relapsing forms of MS. Immunomodulators come in various forms, including proteins, oligonucleotides, biologics, bispecific antibodies, and gene therapies.

By Treatment

Immunosuppressants
Humira
Infliximab
Immunomodulators
Thalidomide
Lenalidomide

By Disease Stage

Relapsing-Remitting Multiple Sclerosis (RRMS)
Secondary Progressive Multiple Sclerosis (SPMS)
Primary Progressive Multiple Sclerosis (PPMS)
Severe Relapsing-Remitting Multiple Sclerosis (RES)

By End User

Hospital and Clinics
Diagnostic Laboratories
Others

Country Scope

Germany
United Kingdom
Spain
France
Italy
Belgium
Sweden
Poland
Russia

Explore in-depth findings on this study by visiting this webpage:https://www.stellarmr.com/report/req_sample/Europe-Multiple-Sclerosis-Treatment-Market/1765

Regional Insights:

Germany is the leading market for MS treatment in Europe and is expected to continue growing at a robust rate. The country boasts one of the largest pharmaceutical industries in Europe, which contributes to improved diagnosis and advancements in MS healthcare infrastructure. Germany’s higher healthcare spending compared to the EU average and its highest per capita healthcare expenditure in the EU further support its prominent position in the market.

Market Key Players:

Neuraxpharm Group
Novartis AG
Roche Holding AG
Merck KGaA
Sanofi
Bayer AG

Click here to access the complete study on this topic:https://www.stellarmr.com/report/Europe-Multiple-Sclerosis-Treatment-Market/1765

Key Offerings:

  • Past Market Size and Competitive Landscape (2018 to 2023)
  • Past Pricing and price curve by region (2018 to 2023)
  • Market Size, Share, Size & Forecast by Different Segment | 2024-2030
  • Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by Region
  • Market Segmentation – A detailed analysis by segment with their sub-segments and Region
  • Competitive Landscape – Profiles of selected key players by region from a strategic perspective
    • Competitive landscape – Market Leaders, Market Followers, Regional player
    • Competitive benchmarking of key players by region
  • PESTLE Analysis
  • PORTER’s analysis
  • Value chain and supply chain analysis
  • Legal Aspects of Business by Region
  • Lucrative business opportunities with SWOT analysis
  • Recommendations

Our Trending Related Report :

Asia Pacific Banking-as-a-Service (BaaS) Market https://www.stellarmr.com/report/Asia-Pacific-Banking-as-a-Service–BaaS–Market/471

North American Storage Tank Market https://www.stellarmr.com/report/North-American-Storage-Tank-Market/145

Asia-Pacific Storage Tank Market https://www.stellarmr.com/report/Asia-Pacific-Storage-Tank-Market/182

South America Storage Tank Market https://www.stellarmr.com/report/South-America-Storage-Tank-Market/190

Europe Casino Gaming Equipment Market https://www.stellarmr.com/report/Europe-Casino-Gaming-Equipment-Market/208

About Stellar Market Research:

Stellar Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

Contact Stellar Market Research:

S.no.8, h.no. 4-8 Pl.7/4, Kothrud,

Pinnac Memories Fl. No. 3, Kothrud, Pune,

Pune, Maharashtra, 411029

[email protected]


Spread the love